Supernus Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8684591089
USD
45.10
0.98 (2.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
1,035.73
921.52
886.20
815.85
744.86
595.43
Shareholder's Funds
1,035.73
921.52
886.20
815.85
744.86
595.43
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
6.89
8.33
408.76
385.73
382.68
370.49
Secured Loans
6.89
8.33
408.76
385.73
382.68
370.49
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
4.96
24.96
49.81
85.35
35.22
-32.06
Other Long Term Liabilities
172.68
197.26
263.22
322.95
221.83
77.14
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
172.68
197.26
263.22
702.20
596.99
441.56
Current Liabilities
Trade Payables
4.59
1.96
10.54
9.33
6.15
10.14
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
292.40
290.20
687.96
315.38
245.11
160.59
Total Liabilities
1,500.81
1,408.98
1,837.38
1,833.43
1,586.95
1,197.57
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
53.87
57.93
57.13
68.77
75.09
51.05
Less: Accumulated Depreciation
17.84
15.40
13.05
16.45
17.04
12.70
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
36.02
42.52
44.08
52.32
58.05
38.35
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
16.62
93.90
119.17
350.36
591.77
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
6.42
7.94
10.41
13.24
23.02
0.61
Total Non-Current Assets
814.74
915.86
1,103.23
1,231.84
956.54
724.93
Current Assets Loans & Advances
Current Investments
384.28
179.82
368.21
136.25
133.89
165.69
Inventories
54.29
77.41
91.54
85.96
48.33
26.63
Sundry Debtors
142.08
144.16
165.50
148.93
140.88
87.33
Cash and Bank
69.33
75.05
93.12
203.43
288.64
181.38
Other Current Assets
649.98
476.44
718.37
574.57
611.74
461.03
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
686.07
493.11
734.15
601.59
630.42
472.64
Net Current Assets (Including Current Investments)
393.67
202.92
46.19
286.21
385.31
312.06
Total Current Assets Excluding Current Investments
686.07
493.11
734.15
601.59
630.42
472.64
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,500.81
1,408.98
1,837.38
1,833.43
1,586.95
1,197.57
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
6.89
8.33
408.76
385.73
382.68
370.49
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -12.46% vs -25.06% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -15.29% vs -3.54% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is -100.00% vs -82.30% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 39.13% vs -32.83% in Dec 2023

Compare Balance Sheet Results of Supernus Pharmaceuticals, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
1,035.73
1,324.81
-289.08
-21.82%
Shareholder's Funds
1,035.73
1,324.81
-289.08
-21.82%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
6.89
7.15
-0.26
-3.64%
Secured Loans
6.89
7.15
-0.26
-3.64%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
4.96
0
4.96
0.00%
Other Long Term Liabilities
172.68
341.64
-168.96
-49.46%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
172.68
341.64
-168.96
-49.46%
Current Liabilities
Trade Payables
4.59
5.85
-1.26
-21.54%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
292.40
59.68
232.72
389.95%
Total Liabilities
1,500.81
1,726.13
-225.32
-13.05%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
53.87
63.31
-9.44
-14.91%
Less: Accumulated Depreciation
17.84
7.73
10.11
130.79%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
36.02
55.58
-19.56
-35.19%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
0.80
-0.80
-100.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
6.42
2.83
3.59
126.86%
Total Non-Current Assets
814.74
350.74
464.00
132.29%
Current Assets Loans & Advances
Current Investments
384.28
1,089.52
-705.24
-64.73%
Inventories
54.29
0
54.29
0.00%
Sundry Debtors
142.08
0
142.08
0.00%
Cash and Bank
69.33
265.05
-195.72
-73.84%
Other Current Assets
649.98
1,363.04
-713.06
-52.31%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
686.07
1,375.39
-689.32
-50.12%
Net Current Assets (Including Current Investments)
393.67
1,315.70
-922.03
-70.08%
Total Current Assets Excluding Current Investments
686.07
1,375.39
-689.32
-50.12%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
1,500.81
1,726.13
-225.32
-13.05%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
6.89
7.15
-0.26
-3.64%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 0.00 Million
in Dec 2024

Figures in Million
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 172.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -12.46% vs -25.06% in Dec 2023

Annual - Fixed Assets
Fixed Assets 36.02 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -15.29% vs -3.54% in Dec 2023

Annual - Investments
Investments 0.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -100.00% vs -82.30% in Dec 2023

Annual - Current Assets
Current Assets 686.07 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 39.13% vs -32.83% in Dec 2023